Pharmacovigilance, Second Edition

Pharmacovigilance, Second Edition

Editor(s): Ronald D. Mann, Elizabeth B. Andrews

Published Online: 7 FEB 2007

Print ISBN: 9780470018033

Online ISBN: 9780470059210

DOI: 10.1002/9780470059210

About this Book

Written by an international team of outstanding editors and contributors, Pharmacovigilance, 2nd Edition is the definitive text on this important subject.  The new edition has been completely revised and updated to include the latest theoretical and practical aspects of pharmacovigilance including legal issues, drug regulatory requirements, methods of signal generation, reporting schemes and pharmacovigilance in selected system-organ classes. . 

  • The editors and contributors are of excellent standing within the pharmacovigilance community
  • The text provides exemplary coverage of all the relevant issues
  • The definitive book on the subject

Table of contents

    1. You have free access to this content
    1. You have free access to this content
  1. Part I: The Basis of Pharmacovigilance

    1. Chapter 1

      Introduction (pages 1–11)

      Hon. Member ISoP Ronald D. Mann and Elizabeth B. Andrews

    2. Chapter 2

      Legal Basis – EU (pages 13–23)

      Nicholas MacFarlane, Paul Brown, Caroline Moore, Claire Taylor, Uwe Froehlich, Tanja Barton, Olivier Banchereau and Paola La Licata

  2. Part II: Signal Generation

    1. Chapter 16

      Spontaneous Reporting – France (pages 217–226)

      Nicholas Moore, Carmen Kreft-Jais and Alban Dhanani

    2. Chapter 25

      PEM in New Zealand (pages 317–332)

      Mira Harrison-Woolrych and David M Coulter

    3. Chapter 26

      MEMO in the United Kingdom (pages 333–340)

      Douglas Steinke, Josie M. M. Evans and Thomas M Macdonald

  3. Part III: Pharmacovigilance and Selected System Organ Classes

    1. Chapter 32

      Dermatological ADRs (pages 395–405)

      Laurence Allanore-Valeyrie and Jean-Claude Roujeau

    2. Chapter 35

      Hepatic ADRs (pages 429–443)

      Guruprasad P. Aithal and Christopher P Day

    3. Chapter 37

      Drug Safety in Pregnancy (pages 455–466)

      Christina D. Chambers and Elizabeth B. Andrews

    4. Chapter 41

      The Cardiovascular Spectrum of Adverse Drug Reactions (pages 507–514)

      Judith Hsia, Jinping Mo, Laura Burleson and Annlouise R. Assaf

  4. Part IV: Key Current Topics

  5. Part V: Lessons and Directions

    1. You have free access to this content